# FDA Inspection 1078054 - Aultman Hospital - February 04, 2019

Source: https://www.keypedia.com/records/fda_inspections/aultman-hospital/cfe2dd04-eafc-4a30-95cd-9e5ffd1c71c4
Source feed: FDA_Inspections

> FDA Inspection 1078054 for Aultman Hospital on February 04, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1078054
- Company Name: Aultman Hospital
- Inspection Date: 2019-02-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1226084 - 2023-12-07](https://www.keypedia.com/records/fda_inspections/aultman-hospital/93812bd7-b5b9-4151-a1a7-4965241de381)
- [FDA Inspection 1115744 - 2020-01-24](https://www.keypedia.com/records/fda_inspections/aultman-hospital/a555f794-d7d3-4501-8662-b674bc7aaf95)
- [FDA Inspection 997341 - 2017-01-17](https://www.keypedia.com/records/fda_inspections/aultman-hospital/af48d51c-6a9a-445c-91b6-fb3fcdca23ab)
- [FDA Inspection 908867 - 2015-01-21](https://www.keypedia.com/records/fda_inspections/aultman-hospital/7d0dd4d1-73ab-4030-97dd-c8a197ae6552)
- [FDA Inspection 817778 - 2013-02-08](https://www.keypedia.com/records/fda_inspections/aultman-hospital/c987b72c-1041-4c3d-844b-4bceb192581a)

Company: https://www.keypedia.com/companies/aultman-hospital/e070240a-db23-4fb9-949a-5560e9ddcba8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d